Atlas Trials

Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx

Clinical trial NCT05257486 · COMPLETED

Trial details

NCT number
NCT05257486
Sponsor
Xoft, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Non-melanoma Skin Cancer
Start date
2022-03-09
Primary completion
2022-07-18
Enrollment
183

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.